Journey Medical (DERM) News
NASDAQ: DERMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.30-0.25 (-7.04%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DERM news summary
We found 3 recent headlines mentioning Journey Medical (DERM): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. DERM is making an outsized move today, down 7.04% at $3.30, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Journey Medical (DERM) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Journey Medical headlines
- Journey Medical (DERM) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate HighlightsTotal revenues were $19.0 million for the third quarter of 2026GlobeNewswireDERM, FBIO
- Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026Company to host conference call to discuss financial results and provide a corporate update on November 12, 2026 at 4:30 p.m. ET Company to host conference call to discuss financial results and…GlobeNewswireDERM, FBIO